Alyssa Dantonio

2.2k total citations
9 papers, 172 citations indexed

About

Alyssa Dantonio is a scholar working on Pharmacology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Alyssa Dantonio has authored 9 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Molecular Biology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Alyssa Dantonio's work include Pharmacogenetics and Drug Metabolism (4 papers), Computational Drug Discovery Methods (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Alyssa Dantonio is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Computational Drug Discovery Methods (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Alyssa Dantonio collaborates with scholars based in United States and United Kingdom. Alyssa Dantonio's co-authors include Jonathan J. Novak, R. Scott Obach, Theunis C. Goosen, Heather Eng, Jill Barber, Mark Niosi, Amin Rostami‐Hodjegan, Brahim Achour, Nandini C. Patel and Gregory S. Walker and has published in prestigious journals such as Drug Metabolism and Disposition and Xenobiotica.

In The Last Decade

Alyssa Dantonio

8 papers receiving 169 citations

Peers

Countries citing papers authored by Alyssa Dantonio

Since Specialization

Citations

This map shows the geographic impact of Alyssa Dantonio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alyssa Dantonio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alyssa Dantonio more than expected).

Fields of papers citing papers by Alyssa Dantonio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alyssa Dantonio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alyssa Dantonio. The network helps show where Alyssa Dantonio may publish in the future.

Co-authorship network of co-authors of Alyssa Dantonio

This figure shows the co-authorship network connecting the top 25 collaborators of Alyssa Dantonio. A scholar is included among the top collaborators of Alyssa Dantonio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alyssa Dantonio. Alyssa Dantonio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Absorption, distribution, metabolism, and excretion tactics toward the expedited discovery and development of the severe acute respiratory syndrome coronavirus-2 main protease inhibitor nirmatrelvir 2025 ·Drug Metabolism and Disposition ·Amit S. Kalgutkar, Heather Eng, Alyssa Dantonio, Eugene P. Kadar, (unknown), Gregory S. Walker, Britton Boras, (unknown)	0
2	The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine Metabolite 2024 ·Drug Metabolism and Disposition ·Martin E. Dowty, Ruolun Qiu, Alyssa Dantonio, Mark Niosi, Angela C. Doran, (unknown), Stephen W. Wright, Gregory S. Walker, Raman Sharma	4
3	Species differences in plasma protein binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease inhibitor nirmatrelvir 2023 ·Xenobiotica ·(unknown), Heather Eng, Qingyi Yang, (unknown), Laura J. Byrnes, Alyssa Dantonio, Graham M. West, Li Di, Amit S. Kalgutkar	3
4	Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans 2022 ·Drug Metabolism and Disposition ·Heather Eng, Alyssa Dantonio, Eugene P. Kadar, R. Scott Obach, Li Di, Jian Lin, Nandini C. Patel, Britton Boras, Gregory S. Walker, Jonathan J. Novak, Emi Kimoto, Ravi Shankar Prasad Singh, Amit S. Kalgutkar	77
5	An Improved Method for Cytochrome P450 Reaction Phenotyping Using a Sequential Qualitative-Then-Quantitative Approach 2022 ·Drug Metabolism and Disposition ·Angela C. Doran, Alyssa Dantonio, (unknown), (unknown), (unknown), Woodrow Burchett, Theunis C. Goosen, R. Scott Obach	7
6	Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting Approach 2022 ·Drug Metabolism and Disposition ·Angela C. Doran, Woodrow Burchett, (unknown), (unknown), (unknown), Heather Eng, Alyssa Dantonio, Theunis C. Goosen, R. Scott Obach	15
7	Intersystem Extrapolation Factors Are Substrate-Dependent for CYP3A4: Impact on Cytochrome P450 Reaction Phenotyping 2021 ·Drug Metabolism and Disposition ·Alyssa Dantonio, Angela C. Doran, R. Scott Obach	9
8	Data Generated by Quantitative Liquid Chromatography-Mass Spectrometry Proteomics Are Only the Start and Not the Endpoint: Optimization of Quantitative Concatemer-Based Measurement of Hepatic Uridine-5′-Diphosphate–Glucuronosyltransferase Enzymes with Reference to Catalytic Activity 2018 ·Drug Metabolism and Disposition ·Brahim Achour, Alyssa Dantonio, Mark Niosi, Jonathan J. Novak, Zubida M. Al‐Majdoub, Theunis C. Goosen, Amin Rostami‐Hodjegan, Jill Barber	21
9	Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic Activity 2017 ·Drug Metabolism and Disposition ·Brahim Achour, Alyssa Dantonio, Mark Niosi, Jonathan J. Novak, John K. Fallon, Jill Barber, Philip C. Smith, Amin Rostami‐Hodjegan, Theunis C. Goosen	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact